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Abstract
Down syndrome (DS) phenotypes result from the overexpression of several dosage-sensitive genes. The DYRK1A (dual-
specificity tyrosine-(Y)-phosphorylation regulated kinase 1A) gene, which has been implicated in the behavioral and
neuronal alterations that are characteristic of DS, plays a role in neuronal progenitor proliferation, neuronal differentiation
and long-term potentiation (LTP) mechanisms that contribute to the cognitive deficits found in DS. The purpose of this
study was to evaluate the effect of Dyrk1A overexpression on the behavioral and cognitive alterations in the Ts65Dn (TS)
mouse model, which is the most commonly utilized mouse model of DS, as well as on several neuromorphological and
electrophysiological properties proposed to underlie these deficits. In this study, we analyzed the phenotypic differences in
the progeny obtained from crosses of TS females and heterozygous Dyrk1A (+/2) male mice. Our results revealed that
normalization of the Dyrk1A copy number in TS mice improved working and reference memory based on the Morris water
maze and contextual conditioning based on the fear conditioning test and rescued hippocampal LTP. Concomitant with
these functional improvements, normalization of the Dyrk1A expression level in TS mice restored the proliferation and
differentiation of hippocampal cells in the adult dentate gyrus (DG) and the density of GABAergic and glutamatergic
synapse markers in the molecular layer of the hippocampus. However, normalization of the Dyrk1A gene dosage did not
affect other structural (e.g., the density of mature hippocampal granule cells, the DG volume and the subgranular zone area)
or behavioral (i.e., hyperactivity/attention) alterations found in the TS mouse. These results suggest that Dyrk1A
overexpression is involved in some of the cognitive, electrophysiological and neuromorphological alterations, but not in the
structural alterations found in DS, and suggest that pharmacological strategies targeting this gene may improve the
treatment of DS-associated learning disabilities.
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Introduction
Down syndrome (DS) is the most common genetic cause of
mental disability.
The Ts65Dn (TS) mouse is the most commonly used and best
characterized segmental trisomic model of DS (see [1,2]). This
mouse exhibits several of the phenotypic characteristics present in
individuals with DS, including cognitive and neuromorphological
alterations and abnormal synaptic plasticity [1–3].
Several trisomic genes have been proposed to play a role in the
cognitive impairments observed in DS individuals and in mouse
models of this condition. One of these genes is dual-specificity
tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A),
which encodes a protein kinase that performs crucial functions
in the regulation of cell proliferation and multiple signaling
pathways [4,5] that contribute to normal brain development and
adult brain physiology [4,6]. Therefore, the DYRK1A gene likely
plays an important role in the cognitive deficits found in DS
[4,5,7].
Evidence for the role of DYRK1A in various DS phenotypes is
derived from studies of several segmental trisomic mouse models of
DS that overexpress different sets of orthologous genes of human
chromosome 21 (Hsa21), including Dyrk1A, and exhibit cognitive
anomalies [1,2]. Transgenic mice overexpressing DYRK1A in
artificial bacterial or yeast chromosomes or carrying extra copies
of the corresponding murine cDNA also exhibit altered learning
and memory [8–11]. In addition, one of these models, YAC152F7
transgenic mice carrying 5 Hsa21 genes, including DYRK1A,
exhibits hippocampal-dependent learning deficits [8,12,13]. To-
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gether, these studies suggest that trisomy of the DYRK1A gene
may contribute to the cognitive disabilities associated with DS.
Overexpression of DYRK1A has also been implicated in the
motor alterations [9,14] found in the DS population [15–17].
Although most studies have failed to detect anomalies in motor
function or coordination in the most commonly used segmental
trisomic model of DS, i.e., the TS mouse [18–20], in various
experimental settings, these animals exhibit hyperactivity that is
indicative of altered attention [20–22], which can compromise
their cognitive performance during multiple tasks.
The cognitive and behavioral alterations found in DS individ-
uals and in the TS mouse model have been attributed to two
primary mechanisms: hypocellularity in various brain areas such
as the hippocampus, the cerebral cortex and the cerebellum, and
enhanced GABA-mediated inhibition (see [1,23]). Multiple studies
suggest that overexpression of Dyrk1A might be involved in some
of these phenotypic alterations. Dyrk1A overexpression inhibits
cell proliferation and induces premature differentiation of neural
progenitor cells in the mouse brain [24,25]. Consistent with these
results, transgenic mice carrying an extra copy of the Dyrk1A gene
exhibited decreased neuronal density in the cerebral cortex [5].
Therefore, Dyrk1A overdosage is implicated in the reduction in
neuronal density found in specific brain regions of individuals with
DS and of TS mice.
One of the mechanisms contributing to the hypocellularity
found in TS mice is impaired pre- and post-natal neurogenesis
[1]. The effects of DYRK1A overexpression on the proliferation
and differentiation of embryonic neural progenitors [6] suggest
that the extra copy of Dyrk1A in the TS mouse may affect the
behavior of postnatal dentate gyrus (DG) progenitor cells, thus,
contributing to the alterations of hippocampal morphology and
function in these mice. Increasing evidence implicates adult
hippocampal neurogenesis in the establishment of long-term
potentiation (LTP) and hippocampal-dependent learning and
memory [26–28].
Another mechanism that has been proposed to underlie the
cognitive function deficits of DS individuals is enhanced inhibition.
Several studies have demonstrated an imbalance between
GABAergic and glutamatergic synapse activity that affects LTP
(see [23]). A recent study has demonstrated anomalous NMDA
receptor-mediated LTP in the prefrontal cortex of mBACtg-
Dyrk1A mice [29], resulting in excessive inhibition. Given the role
of GABA and glutamate transmission in neurogenesis, LTP and
cognitive function [30–33], an imbalance between GABAergic
and glutamatergic synapse activity may also profoundly impair
cognition in DS.
To evaluate the role of Dyrk1A in the cognitive function of
TS mice and in the various mechanisms proposed to underlie
these phenotypic alterations, in this study, we genetically
normalized the Dyrk1A gene dosage in the TS mouse and
demonstrated that the overexpression of this gene is involved in
working and reference memory, contextual fear conditioning
and hippocampal LTP and neuromorphological (cell prolifera-
tion and differentiation in the DG, as well as the density of
GABAergic and glutamatergic synapse markers) abnormalities
found in the hippocampus of this model of DS. In contrast,
Dyrk1A overexpression did not appear to contribute to the
developmental processes that lead to hippocampal structural
changes (hypocellularity, DG volume or subgranular zone (SGZ)
area) or in the hyperactivity, attention or motor alterations
associated with DS.
Materials and Methods
I. Ethics Statement
The University of Cantabria Institutional Laboratory Animal
Care and Use Committee approved this study (License number:
UC2012/02), and the protocols were performed in accordance
with the Declaration of Helsinki and the European Communities
Council Directive (86/609/EEC).
II. Experimental Animals
Mice were generated by repeatedly backcrossing B6EiC3Sn a/
A-Ts (17,16.) 65Dn (TS) females with C57BL/6Ei6C3H/
HeSNJ (B6EiCSn) F1 hybrid males. The Robertsonian Chromo-
some Resource (The Jackson Laboratory, Bar Harbor, ME, USA)
provided the parental generations, and mating was performed at
the animal facilities of the University of Cantabria.
TS females were crossed with Dyrk1A+/2 heterozygous male
mice bred on a mixed C57BL/6-129Ola genetic background [34]
to obtain TS mice carrying a triplicated Mmu16 segment (TS
+/+/+) extending from the Mrp139 gene to the Znf295 gene,
including the Dyrk1A gene; mice trisomic for all of these genes but
diploid for Dyrk1A (TS +/+/2); and euploid (CO) mice
containing a normal Dyrk1A dosage (CO +/+).
To determine trisomy, the animals were karyotyped using real-
time quantitative PCR, as previously described [35]. C3H/HeSnJ
mice carry a recessive mutation that leads to retinal degeneration
(Rd); therefore, all of the animals were genotyped using standard
PCR to detect the Rd mutation [36]. Experiments were conducted
using wt/wt or Rd1/wt animals. The Dyrk1A+/2 mice were
genotyped using PCR, as previously described [34].
Mice were housed in groups of two or three in clear plexiglass
cages (20622620 cm) under standard laboratory conditions with
a temperature of 2262uC, a 12-hour light/dark cycle and free
access to food and water. The light/dark cycle was inverted to
conduct the behavioral studies during the active period of the
mice.
A total of 36 male mice were evaluated for one month in the
behavioral studies (12 TS +/+/+, 12 TS +/+/2, and 12 CO +/+).
In each behavioral experiment, animals were evaluated one at a
time. After completion of the behavioral studies, the mice were
sacrificed at the age of 6–7 months; 6 animals from each group
were used for the histological experiments, and the remaining
animals were used for the determination of Dyrk1A protein levels.
To assess LTP, we used 6 animals (5–6 months of age) from each
group that had not been previously utilized in the behavioral
studies. The researchers were blinded to the genotype and
karyotype throughout the entire assessment. The behavioral
studies were performed in the Behavioral Laboratory of the
Animal Facilities in the University of Cantabria. Western blot
analysis and immunohistochemical experiments were performed
in the Laboratory of Neurobiology of Learning of the Department
of Physiology and Pharmacology of the University of Cantabria;
the electrophysiological experiments were conducted in the
Laboratory of Electrophysiology located in this department of
the University of Cantabria.
III. Western blot analysis
Immunodetection of the Dyrk1A protein was performed using
the hippocampi of six animals from each experimental group.
Mice were euthanized by decapitation, the brains were rapidly
removed, and the hippocampus and cortex were dissected. Lysates
were prepared as previously described [37]. Total protein content
of the samples was determined using the method of Lowry et al.
[38]. Identical amounts of total protein from each sample were
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loaded on a 10% sodium dodecyl sulfate-polyacrylamide gel,
electrophoresed and transferred to a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad) using a Mini Trans-Blot Electro-
phoretic Transfer Cell (Bio-Rad). Nonspecific binding of antibod-
ies was prevented by incubating the membranes in TBST buffer
(10 mM Tris-HCl, pH 7.6, 150 mM NaCl, and 0.05% Tween 20)
containing 5% nonfat milk powder. The blots were incubated with
a mouse monoclonal anti-DYRK1A antibody (1:250; Abnova
Corporation, Taipei, Taiwan, ROC) diluted in TBST containing
2% bovine serum albumin (BSA) overnight at 4uC. After extensive
washing with TBST, the blots were incubated with a goat anti-
mouse IRDye 800CW antibody (1:10.000, LI-COR Biotechnol-
ogy, Lincoln, Nebraska, USA) for 1 h at room temperature. The
fluorescence was detected and quantified using a LI-COR
ODYSSEY IR Imaging System V3.0 (LI-COR Biotechnology,
Lincoln, Nebraska, USA). The integrated optical density of the
bands was determined (ImageJ software, version 1.45 s; http://
rsb.info.nih.gov/ij, National Institutes of Health, MD, USA) and
normalized to the background values. The relative variations
between the bands of the three groups of experimental mice were
calculated using an identical film. Each individual sample was
evaluated in at least three independent experiments. The values
were within a linear range. To ensure equal loading, the blots were
reprobed using a mouse monoclonal anti-GAPDH antibody (6C5)
(1:2000; Santa Cruz Biotechnology, Santa Cruz, CA, USA).
IV. Behavioral studies
To decrease the chances of behavioral responses being altered
by prior test history, the most invasive procedures were performed
last. Studies were performed in the following order: motor test,
rotarod test, open field test, Morris water maze and fear
conditioning.
1. Cognitive tests. The Morris Water Maze test was
performed to evaluate spatial learning using a circular tank of
120 cm in diameter that was filled with water maintained at 22–
24uC. Powdered milk was added to give the water an opaque
appearance. Inside the tank, a platform was hidden 1 cm below
the water level.
The animals were tested in 12 consecutive daily sessions
consisting of 8 acquisition sessions (platform submerged) followed
by 4 cued sessions (platform visible). All of the trials were
videotaped using a camera located 2 m above the water level. An
Anymaze computerized tracking system (Stoelting, Wood Dale,
IL, USA) was used to analyze the swimming trajectories, measure
the escape latency, the path efficacy (an index of the similarity
between the trajectory of each animal and the shortest trajectory
to the escape platform), thigmotaxis and the swimming speed per
animal for each trial.
In this study, we used the platform relocation protocol. This
paradigm has been consistently used to assess learning and
memory abilities in various experimental models of disease [39–
42].
In the acquisition sessions (S1–S8), the platform was hidden
1 cm below the water level. During these sessions the platform
position was changed every day.
In this protocol, the within-session (between-trial) performance
analysis provides a measure of working memory (i.e., the animals
search for the platform during the first trials, encode its location
and then remember it on the remaining trials of the day).
Therefore, effective performance required the retrieval of recent
information, or ‘‘working memory’’ [43]. However, for each new
session, the animal must learn a new platform position. Therefore,
a ‘‘between-session’’ performance analysis provides a measure of
‘‘reference memory’’. As the sessions progress, the animal must
construct a stable long-term memory representation of the
environment (i.e., a ‘‘coordinate’’ map), which can be considered
the reference memory component of the task, separate from the
representation of the most recent location in which the hidden
platform was located. Moreover, throughout the sessions, the
animal must learn to inhibit maladaptive behaviors, such as
swimming along the walls, and to choose a strategy to search for
the platform in the tank. Therefore, ‘‘between-session’’ perfor-
mance analysis also provides a measure of the learning and
memory abilities of the animals.
Each of the 8 acquisition sessions and 4 cued sessions (one
session per day) consisted of four pairs of trials at 30–45 min
intervals. In each pair of trials, the mice were randomly started
from one of the four positions (N, S, E or W), which were held
constant for both trials. The first trial of the pair was terminated
when the mouse located the platform or when 60 s had elapsed;
the second trial commenced following a period of 20 s, during
which the mouse was allowed to remain on the platform. Several
fixed visual cues outside the maze were constantly visible from the
pool.
During the 4 cued sessions, the platform was visible; the water
level was 1 cm below the top of the platform, and its position was
indicated with a flag. Eight trials were performed during each
session according to an experimental procedure that was identical
to the procedure used in the acquisition sessions.
For the Fear conditioning experiment the procedure was
performed as described by Salehi et al. [44]. Briefly, contextual
and tone-cued fear conditioning tests were performed using the
Fear Conditioning apparatus (Stoelting) and the AnyMaze Video
Tracking System (Stoelting). The mice underwent three days of
testing: a training day, a tone-cued in a novel context testing day
and a contextual testing day. On the first day, the mice went
through the training session. Prior to conditioning, each mouse
was allowed to explore the test chamber for 3 min (baseline
activity). Then, each mouse received five tone-shock pairings. The
shock (0.5 mA, 50 Hz, 2 sec) was delivered 18 sec after the end of
the tone (70 dB, 2 kHz, 20 sec). Therefore, there was an empty
trace interval interposed between the tone and the shock for each
conditional stimulus-unconditional stimulus pairing. On the
second day (the tone-cued testing day), each mouse was placed
in a novel context (new olfactory and visual cues) for 3 min and
was subsequently presented with three tone exposures (identical to
the training day) without any shocks. On the final day of the
experiment, each mouse was placed in a context similar to the
training day for 5 min without any tones or shocks. The freezing
behavior of the mice under each condition was quantified on both
testing days.
2. Motor tests. A battery of motor tests was performed
following the procedure described by Martı´nez-Cue´ et al. [20]. In
the visual placing reflex test, the cerebellar and vestibular functions
were evaluated. In 3 consecutive trials, mice were gently lowered
by the tail towards a flat surface from a height of 15 cm. The
response of forepaw extension was scored on a 0–4 scale (4: animal
extends the forepaws when placed at the highest height; 3:
forepaws extended before touching the surface with vibrissae; 2:
forepaws extended after vibrissae touched the surface; 1: forepaws
extended after the nose touched the surface; and 0: no extension).
Grip strength was assessed by quantifying the resistance to
separation from the aluminum bars (2 mm) of a lid when pulled by
the tail (0: no resistance; 1: slight; 2: moderate; 3: active; and 4:
extremely active resistance).
To evaluate the equilibrium of the mice, four 20-s trials of
balance were performed on an elevated (40 cm high), horizontal
(50 cm long) rod. Trials 1 and 2 were performed on a flat wooden
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rod (9 mm wide); trials 3 and 4 were performed on a cylindrical
aluminum rod (1-cm diameter). In each trial, the animals were
placed in a marked central zone (10 cm) on the elevated rod. A
score of 0 was given if the animal fell within 20 s, 1 if it remained
within the central zone for .20 s, 2 if it left the central zone, and 3
if it reached one of the ends of the bar.
Prehensile reflex (three 5-s trials) was measured from the ability
of the animal to remain suspended by the forepaws by grasping an
elevated horizontal wire (2 mm in diameter). The maximum
possible score was achieved when the animal remained suspended
by the forepaws in all three trials (one point per trial). Traction
capacity was simultaneously scored by assessing the number of
hind limbs that the animal raised to reach the wire (0: none; 1: one
limb; and 2: two limbs).
Motor coordination was evaluated using a rotarod device (Ugo
Basile, Comerio, Italy), which consists of a 37-cm-long, 3-cm
diameter plastic rod that rotates at different speeds. In a single
session, 5 trials with a maximum duration of 60 s each were
performed. In the first four tests, the rod was rotated at constant
speeds of 10, 20, 30 or 50 rpm, respectively. The last trial
consisted of an acceleration cycle, in which the rod rotated
progressively faster, and the animal had to adapt to the growing
demands of the test. The length of time that each animal remained
on the rotarod during the acceleration cycle was recorded.
Exploratory behavior and anxiety were assessed using a square-
shaped open field (55 cm655 cm, surrounded by a 25-cm-high
fence) divided into 25 equal squares. The mice were placed in the
center of the field, and the number of vertical (rearing) activities
and horizontal crossings (from square to square, subdivided into
center vs. peripheral crossings) were scored in a single 5-min trial.
V. Long-term potentiation
The mice were decapitated, and the brains were rapidly
removed. The hippocampi were dissected, and 400-mm slices were
generated using a tissue chopper. The slices were allowed to
recover for 1 hour in an interface chamber at room temperature in
artificial cerebral spinal fluid (ACSF) containing 120 mM NaCl,
3.5 mM KCl, 2.5 mM CaCl2, 1.3 mM MgSO4, 1.25 mM
NaH2PO4, 26 mM NaHCO3 and 10 mM D-glucose saturated
with 95% O2 and 5% CO2. Field excitatory postsynaptic
potentials (fEPSPs) were recorded from the CA1 stratum radiatum
using a glass micropipette (1–4 MV) containing 2 M NaCl, and the
Schaffer collaterals were stimulated using insulated bipolar
platinum/iridium electrodes located .500 mm from the recording
electrode. The stimulus strength was adjusted to evoke fEPSPs
equal to 50% of the relative maximum amplitude without a
superimposed population spike. After stable baseline recordings
(100-ms pulse duration, 0.033 Hz), long-term potentiation (LTP)
was induced with TBS (10 trains of 5 pulses at 100 Hz and
intervals of 200 ms). The duration of the stimulation pulses was
doubled during tetanus. fEPSPs were amplified, bandpass filtered
(1 Hz-1 kHz) and stored in a computer using the Spike2 software
program (Cambridge Electronic Design, Cambridge, UK). For the
analysis, the fEPSP slopes were expressed as a percentage of the
recorded baseline values. The results from several slices were
expressed as the mean value 6 SEM.
VI. Histological and stereological procedures
The animals were deeply anesthetized with pentobarbital
(50 mg/kg) and transcardially perfused with saline followed by
4% paraformaldehyde. Subsequently, the brains were postfixed in
4% paraformaldehyde overnight at 4uC and transferred to 30%
sucrose. The brains were frozen in dry ice and coronally sliced in a
cryostat (50-mm thick sections). Series of brain slices comprising
1 section of every 9 were used for the immunohistochemistry
protocol. A 1-in-9 series of coronal sections was randomly selected
and subjected to Nissl staining using the Cavalieri method, as
previously described [45], to calculate the SGZ area and the DG
volume.
1. Granule cell counts. The cells in the hippocampal
granule cell layer (GCL) were counted in sections stained with
496-diamidino-2-phenylindole (DAPI, Calbiochem, Billerica, MA,
USA; 1:1,000) for 10 min in phosphate buffer (PB). The cell
counts were obtained using a confocal microscope coupled to a
physical dissector system, as previously described [45]. Six
dissector locations in each series were evaluated. In the selected
locations, the confocal microscope was randomly directed toward
a previously established position within the GCL. Subsequently, a
series of confocal images was serially recorded according to the
general principles of the physical dissector and the unbiased
stereology methods. The confocal images were analyzed using the
ImageJ software. The cells were counted cell-by-cell using a digital
tablet upon the first appearance of labeled cells in each series of
confocal images. The software generated the total number of cells
when the dissector brick was completed. To count the total
number of cells in the GCL, a square dissector frame was
randomly situated inside the GCL. To obtain the number of cells
per unit of volume (cell density), the obtained cell number was
divided by the reference volume of the dissector; this parameter is
the volume of a prism formed by the area of the frame multiplied
by the height of the dissector.
2. Cell proliferation in the SGZ of the DG (Ki67
immunofluorescence). Ki67 immunofluorescence was per-
formed to identify proliferating cells. The sections were preincu-
bated in PBTBSA (PB containing 0.5% Triton X-100 and 0.1%
BSA), and immunohistochemistry was performed, as previously
described [45]. Briefly, free-floating sections were incubated with a
primary rabbit anti-Ki67 antibody (1:750; Abcam, Cambridge,
UK) for two days at 46C. Subsequently, the slices were incubated
overnight at 46C with a secondary antibody diluted 1:1,000
(donkey anti-rabbit-Alexa Fluor 488; Molecular Probes, Eugene,
OR, USA). The sections were counterstained with DAPI and
mounted on gelatin-covered slides for analysis and imaging. The
total number of Ki67-positive cells was counted under an optical
fluorescence microscope (Zeiss Axioskop 2 Plus, 40x objective)
using the optical dissector method, as previously described [45].
3. Neuronal differentiation (DCX and CLR
immunofluorescence). One-in-nine series of 50-mm sections
were used for the determination of the density of cells expressing
immature markers (doublecortin (DCX) and/or calretinin (CLR)).
The sections were initially preincubated in PBTBSA, and dual
immunohistochemistry was subsequently performed. A goat anti-
doublecortin antibody (1:250; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and a rabbit anti-calretinin antibody (1:3000;
Swant, Switzerland) were used as primary antibodies. The primary
antibodies were labeled with a donkey anti-goat Alexa Fluor 594-
conjugated antibody and a donkey anti-rabbit Alexa Fluor 488-
conjugated antibody, respectively (1:1000; Alexa Fluor-conjugated
antibodies purchased from Invitrogen, Carlsbad, CA, USA). The
sections were subsequently imaged using a confocal microscope
(Leica SP5). Quantification of the DCX- and CLR-expressing cells
was performed according to stereological procedures using the
physical dissector method, as previously described by Llorens-
Martin et al. [45]. To evaluate the cells expressing the immature
markers, six random dissectors per animal were used, comprising
sections of the entire hippocampus. A series of 11 confocal images
was serially recorded in each physical dissector. All of the
immature cells were counted using the physical dissector, which
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has a square area with one side that lies on the ‘‘line’’ of the SGZ.
By dividing the number of counted immature cells by the length of
the ‘‘subgranular’’ line, a reliable estimate of the cell density by
‘‘unit of SGZ’’ was obtained. The cell density of the immature
neurons is presented as either DCX+ (DCX+/CLR-) or CLR+
(DCX+/CLR+ plus DCX2/CLR+).
4. Density of GABAergic and glutamatergic synapse
markers (GAD65/67 and VGLUT1
immunofluorescence). One-in-nine serial 50-mm sections of
mouse brains were used to determine the density of GABAergic
and glutamatergic synapse markers. The sections were initially
preincubated in PBTBSA, and dual immunohistochemistry was
subsequently performed. The glutamatergic and GABAergic
boutons were labeled using a guinea pig anti-vesicular glutamate
transporter 1 antibody (VGLUT1, 1:2,500; Millipore, Billerica,
MA, USA) and a rabbit anti-glutamic acid decarboxylase 65/67
antibody (GAD65/67, 1:350; Millipore, Billerica, MA, USA)
respectively. This labeling was followed by additional labeling with
Alexa Fluor 488-conjugated goat anti-guinea pig IgG (1:1,000;
Invitrogen, Carlsbad, CA, USA) and a donkey anti-rabbit Alexa
Fluor 594-conjugated antibody (1:1,000; Invitrogen, Carlsbad,
CA, USA).
Measurements were performed on images obtained using a
confocal microscope (Leica SP5). For each synapse marker, four
sections per animal were used, constituting the entire hippocam-
pus, and one random area in the hippocampus per section was
measured. Image analysis was performed using the ImageJ
software as previously described [20]. Briefly, boutons with
positive immunofluorescence (either VGLUT1 or GAD65/67
because these markers do not colocalize) were separately
measured, applying an identical threshold to all images. The
images were converted to grayscale to improve the contrast
between signal and noise. The area was measured inside of a
reference circle with a standard size of 325 mm2. The reference
space was located in the inner molecular layer of the hippocampal
DG, which lines the most external layer of granule neurons in the
GCL. The percentage of the reference area occupied by
VGLUT1- and GAD65/67-positive boutons was calculated.
VII. Statistical Analysis
The data obtained from the MWM test experiments were
analyzed using a two-way ANOVA with repeated measures
(‘session6trisomy6Dyrk1A’ or ‘trial6trisomy6Dyrk1A’). LTP
data were analyzed using a RM MANOVA (‘time6trisomy6
Dyrk1A’). The remaining data were analyzed using a two-way
(‘trisomy’6‘Dyrk1A’) ANOVA. The mean values for each
experimental group were compared post-hoc using Bonferroni
tests. All of the analyses were performed using SPSS for Windows
version 21.0.
Results
I. Normalization of the Dyrk1A expression level improved
spatial working and reference memory and contextual
fear conditioning of TS mice
To assess the contribution of the increased Dyrk1A expression
level to various structural and functional alterations characteristic
of DS, we crossed TS females and heterozygous Dyrk1A (+/2)
mice and evaluated the different phenotypes in the progeny. TS
+/+/+ mice exhibited a 50% increase in Dyrk1A protein
expression (p,0.001) in the hippocampus. Normalization of the
Dyrk1A gene copy number in TS +/+/2 mice reduced the extent
of Dyrk1A protein expression to a level similar to that found in
CO +/+ mice (p,0.001; Figure 1).
After verifying that the expression level of Dyrk1A correlates
with the copy number of this gene, we examined the performance
of TS +/+/+, TS+/+/2 and CO +/+ mice on the MWM task
using a protocol that allows for assessment of both working
(between-trial performance analysis) and reference (between-
session performance analysis) memory. All three groups of mice
were able to learn the platform position over the course of the
sessions (Figure 2a). TS +/+/+ mice exhibited an increased
latency to reach the platform throughout the sessions, suggesting a
profound impairment in reference memory. Remarkably, removal
of one copy of Dyrk1A from the TS mice (TS +/+/2 mice)
improved their cognitive performance (p = 0.006; Figure 2a)
based on the decrease in their latency to reach the platform in
sessions 1 through 6. However, during the last two sessions, the
performance of the TS +/+/2 mice did not differ from that of TS
+/+/+ mice, indicating that the improvement in reference
memory in this group of animals was only partial. Alternatively,
when the performance of the different groups of mice was
analyzed within each session (i.e., the latency to reach the platform
in each trial across the 8 sessions), the TS +/+/+ mice exhibited a
significant severe deficit in working memory compared with CO
+/+ mice (p,0.001, Figure 2b). Reducing one copy of Dyrk1A
from the TS mice significantly improved their performance
throughout the trials (p,0.001). In fact, when the slopes of the
learning curves of each group of mice were analyzed separately, it
was found that the TS +/+/+ mice did not learn to locate the
platform position within each session because they did not reduce
their latency to reach the platform over the course of the trials
(p = 0.17, Figure 2b), while both the CO +/+ (p = 0.029) and TS
+/+/2 mice (p = 0.028) significantly reduced their latency to
reach the platform over the course of the trials; i.e., they learned
the new platform position during each session. These results
suggest that reduction of one copy of Dyrk1A ameliorated the
impairment in working memory found in TS +/+/+ mice.
Next, we estimated the efficacy of learning by calculating an
index of the similarity between each animal’s route to reach the
platform and the shortest possible trajectory from the starting
point to the platform. As illustrated in Figure 2c, TS +/+/+ mice
displayed poor efficacy in searching for the platform throughout
the sessions compared to the euploid mice; however, normaliza-
tion of Dyrk1A expression in TS +/+/2 mice improved their
efficacy in the searching for the platform throughout the 6 sessions
(p = 0.003). In addition, the TS +/+/+ mice exhibited enhanced
thigmotactic behavior throughout the sessions compared with the
CO +/+ mice (p,0.001, Figure 2d), and normalization of the
Dyrk1A copy number in the TS mice significantly reduced their
thigmotactic behavior based on their reduced tendency to swim in
the periphery of the maze (p,0.001), indicating an improvement
in their strategy of searching for the escape platform.
No significant differences in performance were detected
between the three groups of mice during the cued trials (Figure 2f)
or in the swimming speed during the entire task (Figure 2e).
Therefore, the differences found during the acquisition sessions are
unlikely to be due to alterations in motor function or motivation to
escape from the pool.
For the fear conditioning test, the TS +/+/+ mice exhibited a
deficit in remembering the association between the tone and the
shock, as demonstrated by their reduced freezing time in the cued
test (p = 0.01, Figure 2g). Normalization of the Dyrk1A copy
number did not rescue this phenotype in the TS mice. In the
context conditioning test, the TS +/+/+ animals did not
remember the association between the shock and the context as
efficiently as the euploid mice based on their reduced freezing time
during this session (p,0.001). However, this alteration was
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partially ameliorated in TS +/+/2 animals. Although this effect
was not significant compared with the euploid mice (p = 0.11;
Figure 2g), post-hoc analysis of both groups of trisomic mice
indicated an enhancement of this mode of cognitive function in the
TS +/+/2 mice compared with the TS +/+/+ mice, as the
trisomic mice with normal Dyrk1A gene dosage exhibited an
increased freezing time compared with that of mice with three
copies of this gene (p = 0.045). Therefore, normalizing the Dyrk1A
copy number improved contextual but not cued fear conditioning
in the TS mice.
II. Normalization of the Dyrk1A copy number did not
affect motor coordination based on the rotarod test,
general activity or anxiety in the open field test or
various motor functions
Motor function, motor coordination and general activity and
anxiety were evaluated using a motor test battery, the rotarod test
and the open field test respectively. Consistent with the lack of
motor alterations detected based on the MWM test, the three
groups of mice did not differ with respect to their motor
coordination or the abilities assessed using various behavioral
tests. No significant differences were found in the rotarod fall
latency between the TS +/+/+, TS +/+/2 and euploid mice
when the rod was rotating at varying constant speeds (Figure 3a)
or at an accelerating rate (Figure 3b). In addition, in the present
study, the TS +/+/+ mice did not exhibit any alteration in
equilibrium, motor coordination or most of the motor reflexes
analyzed, and reducing the Dyrk1A copy number did not affect
any of these motor functions (table 1). These results indicate that
neither trisomy nor the Dyrk1A copy number affected motor
coordination.
To evaluate anxiety and general activity in the three groups of
animals, the open field test was performed (Figure 3c). This
experimental setting has been traditionally used to analyze anxiety
and general activity in mice. Although the evaluation of anxiety
was not the aim of this study, numerous studies have consistently
demonstrated the hyperactive behavior of TS animals exposed to
this maze (see [2]). Therefore, the open field test is ideal to
evaluate changes in this behavioral abnormality. On this test, no
significant differences were found in anxiety based on the distance
traveled by the mouse in the center of the maze. However, the TS
+/+/+ mice traveled a larger distance at the periphery of the maze
and a larger total distance than the CO +/+ mice, indicating
hyperactivity of the trisomic animals in this test. Normalizing the
Dyrk1A copy number slightly reduced this hyperactivity in these
animals, but this effect did not reach statistical significance.
III. Normalization of the Dyrk1A gene dosage rescued LTP
in TS mice
To evaluate the effect of the Dyrk1A gene dosage on the altered
hippocampal plasticity of TS mice, we recorded fEPSPs in
hippocampal slices obtained from the three groups of mice. A
theta burst stimulus (TBS) was used to induce LTP in the CA1
region. The TS +/+/+ mice displayed a pronounced impairment
of LTP (p = 0.003; Figure 4). Importantly, normalization of the
Dyrk1A copy number in the TS mice significantly increased the
amount of LTP (TS +/+/+ vs. TS +/+/2: p = 0.008) to levels that
completely abolished the deficit found in the TS +/+/+ mice (TS
+/+/2 vs. CO +/+: p = 0.17).
IV. Normalization of the Dyrk1A expression level reduced
the density of GABAergic and enhanced glutamatergic
synapse markers in the hippocampus in TS mice
Consistent with previous studies (see [23]), in this study, the TS
+/+/+ mice exhibited enhanced expression of the GABAergic
synapse marker GAD65/67 and reduced expression of the
glutamatergic synapse marker VGLUT in the molecular layer of
the hippocampus. The TS +/+/2 mice displayed a reduction in
the expression of the inhibitory GABAergic marker GAD65/67
compared to the TS +/+/+ mice (Figure 5). In addition, the
decrease in the expression of the excitatory synapse marker found
in the TS +/+/+ mice was ameliorated after reducing the Dyrk1A
gene dosage, as demonstrated by the increase in the area occupied
by VGLUT-positive boutons in the TS +/+/2 animals (Figur-
es 5a and b). The calculated ratios of the expression of the two
markers revealed that the TS +/+/2mice displayed a significantly
improved balance of excitatory/inhibitory synapse marker expres-
sion, although these mice did not express the same levels of these
markers as euploid animals (Figure 5). These results indicate that
Dyrk1A overexpression affects the density of inhibitory and
excitatory synapses and suggests that it contributes to the
imbalance between excitatory and inhibitory synapse marker
expression found in TS +/+/+ animals. Together, these results
indicate that normalizing the Dyrk1A copy number in TS mice
improved the balance between excitatory and inhibitory synapse
markers compared to trisomic mice.
V. Normalization of the Dyrk1A dosage rescued neuronal
proliferation and differentiation but not survival in the
hippocampus of TS mice
To determine whether normalization of the Dyrk1A dosage
would rescue the impairment in adult hippocampal neurogenesis
in TS mice, we first analyzed the population of proliferating cells
in the SGZ of the DG. Consistent with numerous studies [1,20],
Figure 1. Normalization of the Dyrk1A copy number reduced Dyrk1A protein expression in the hippocampus of TS mice.Western blot
analysis of Dyrk1A protein levels in the hippocampus of CO +/+, TS +/+/+ and TS +/+/2 mice. Differences in the TS +/+/+ and TS +/+/2 mice are
expressed relative to the values of CO +/+ mice (defined as 100%). ANOVA ‘trisomy’: F(1,17) = 22.79, p,0.001, ‘Dyrk1A’: F(1,17) = 14.40, p,0.001. ***:
p,0.001 TS +/+/+ vs. CO +/+; ##: p,0.01 Dyrk1A +/+/+ vs. Dyrk1A +/+/2; Bonferroni tests after significant MANOVAs.
doi:10.1371/journal.pone.0106572.g001
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Figure 2. Normalization of the Dyrk1A protein expression levels in the hippocampus improved spatial working and reference
memory and contextual fear conditioning in TS mice. Data are presented as the mean values 6 SEM (a) of the latency to reach the platform
during the acquisition sessions (between-session analysis: RM ANOVA: ‘session’ F(7,35) = 48.29, p,0.001; ‘trisomy’: F(1,35) = 44.20, p,0.001; ‘Dyrk1A’:
F(1,35) = 7.98, p = 0.006); (b) of the latency to reach the platform in each trial across the 8 acquisition sessions (within-session analysis: ‘trial’
F(7,35) = 14.57, p = 0.001, p,0.001; ‘trisomy’: F(1,35) = 23.65, p,0.001; ‘Dyrk1A’: F(1,35) = 13.47, p = 0.001); (c) of the efficacy of the learning score
(‘session’ F(7,35) = 22.31, p,0.001; ‘trisomy’: F(1,35) = 34.40, p,0.001; ‘Dyrk1A’: F(1,35) = 9.70, p = 0.003); (d) of the percentage of time spent in the
periphery of the pool during the 8 sessions (‘session’ F(7,35) = 21.94, p,0.001; ‘trisomy’: F(1,35) = 13.92, p,0.001; ‘Dyrk1A’: F(1,35) = 8.52, p,0.001); (e)
of the mean swimming speed (ANOVA ‘trisomy’: F(1,35) = 0.03, p = 0.84; ‘Dyrk1A’: F(1,35) = 0.07, p = 0.78); (f) of the mean latency to reach the platform
in the 4 averaged cued sessions (ANOVA ‘trisomy’: F(1,35) = 0.01, p = 0.91; ‘Dyrk1A’: F(1,35) = 1.58, p = 0.21) in the MWM test and (g) of the freezing
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the TS +/+/+ mice exhibited a reduced density of Ki67+ cells in
the SGZ compared with the CO +/+ mice (Figures 6a and b),
indicating altered adult hippocampal cell proliferation. Remark-
ably, normalization of the Dyrk1A copy number in the TS mice
completely recovered the density of Ki67+ cells.
Subsequently, we quantified neuronal differentiation using
specific markers for proteins expressed by neuroblasts and
immature neurons in the adult hippocampus in consecutive stages
of neuronal maturation. As expected, the TS +/+/+ mice
exhibited fewer DCX+ and CLR+ cells in the SGZ than the
CO +/+ mice (Figures 6a and b). However, the number of
DCX+ and CLR+ cells in the TS +/+/2 mice was similar to that
in the control animals (Figures 6a and b). Therefore, normalizing
the expression level of Dyrk1A in TS+/+/+ animals rescued these
deficits in neuronal differentiation.
When we estimated the density of mature neurons by counting
the DAPI-labeled nuclei in the GCL, we found that the TS +/+/+
mice exhibited marked hypocellularity, as previously described.
However, the density of the DAPI+ nuclei of the TS +/+/2 mice
was similar to that of the TS +/+/+ mice (Figures 6a and b).
These results indicate that although normalization of the Dyrk1A
gene dosage in TS animals improved the defects in proliferation
and differentiation previously found in the hippocampus of adult
TS +/+/+ mice, the newly generated neurons in TS +/+/2 mice
did not survive to integrate into functional circuits.
VI. Normalization of the Dyrk1A gene dosage did not
affect the DG volume, the SGZ area or the body weight
of TS +/+/+ mice
We evaluated the possible effect of Dyrk1A trisomy on the DG
volume and the SGZ area. Adult TS +/+/+ mice exhibited a
time during the cued and contextual conditioning tests (Cued conditioning: ANOVA ‘trisomy’: F(1,35) = 7.42, p = 0.01; ‘Dyrk1A’: F(1,35) = 0.01, p = 0.97;
Contextual conditioning: ANOVA ‘trisomy’: F(1,35) = 18.64, p,0.001; ‘Dyrk1A’: F(1,35) = 5.54, p = 0.11). *: p,0.05, **: p,0.01, ***: p,0.001 TS +/+/+ vs.
CO +/+; #: p,0.05, ##: p,0.01 Dyrk1A +/+/+ vs. Dyrk1A +/+/2; Bonferroni tests after significant MANOVAs.
doi:10.1371/journal.pone.0106572.g002
Figure 3. Normalization of the Dyrk1A copy number did not affect motor coordination in the rotarod test or the levels of general
activity and anxiety in the open field test. Mean values6 SEM of the latency to fall from the rotarod at different constant speeds (a) and during
the acceleration cycle (b) or of the activity performed by the three groups of mice in the open field test (c). Rotarod constant speeds: ANOVA
‘trisomy’: F(1,35) = 0.72, p = 0.40; ‘Dyrk1A’: F(1,35) = 1.82, p = 0.18. Acceleration cycle: ANOVA ‘trisomy’: F(1,35) = 0.72, p = 0.40; ‘Dyrk1A’: F(1,35) = 1.69,
p = 0.20. Open field periphery: ANOVA ‘trisomy’: F(1,35) = 6.36, p = 0.014; ‘Dyrk1A’: F(1,35) = 0.70, p = 0.17; Center: ANOVA ‘trisomy’: F(1,31) = 2.21,
p = 0.14; ‘Dyrk1A’: F(1,31) = 0.17, p = 0.68; Total: ANOVA ‘trisomy’: F(1,35) = 5.39, p = 0.023; ‘Dyrk1A’: F(1,35) = 1.77, p = 0.67. *: p,0.05 TS +/+/+ vs. CO
+/+; Bonferroni tests after significant MANOVAs.
doi:10.1371/journal.pone.0106572.g003
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smaller DG volume and SGZ area than the CO +/+ mice
(Figures 7a and b), and these reductions were not rescued by
normalization of the Dyrk1A gene dosage (Figures 7a and b).
This result suggests that Dyrk1A is not involved in these
hippocampal morphological defects in TS +/+/+ mice.
In addition, the reduced body weight found in TS mice (from
birth to the age of 5–6 months) was not significantly modified by
normalization of the Dyrk1A gene dosage (Figure 7c).
Discussion
This study reveals that normalizing the Dyrk1A gene dosage in
the TS mouse improves hippocampal-dependent learning, possibly
due to the recovery of synaptic plasticity (LTP), the enhancement
of adult hippocampal cell proliferation and differentiation and/or
the improvement of the balance between inhibitory and excitatory
synapse markers. Therefore, this study provides evidence for the
role of this gene in multiple important DS phenotypes. However,
normalization of the Dyrk1A gene dosage did not display any
effect on several structural (e.g., the density of mature hippocam-
pal granule cells, the DG volume and the SGZ area) and
behavioral (hyperactivity) abnormalities found in the TS mice (see
summary in Table 2).
Consistent with numerous reports [1,20], TS +/+/+ mice
exhibited a profound impairment in reference and working
memory based on the MWM test. However, normalizing the
Dyrk1A copy number enhanced the cognitive abilities of the TS
mice. The TS +/+/2 mice exhibited an improvement in the
working and reference memory components of the task, in their
searching strategy (i.e., the efficiency of their trajectories to reach
the escape platform) and in their thigmotactic behavior compared
with the TS +/+/+ mice. These effects were not due to changes in
motor function, as no alteration was found in the swimming speed
of TS +/+/2 mice or in their performance during the cued
sessions, the motor test battery or the rotarod test. These results
are consistent with those of previous studies that did not find
alterations in motor coordination in the rotarod test in Ts65Dn
mice [18–20]; however, other studies have found that these mice
exhibit poorer motor coordination than euploid mice in this test
[46]. The discrepancies between these studies are most likely due
to differences in the experimental protocol used; for example, the
difficulty of the task used in the study by Costa et al. [46] was
higher than that used in the other studies. In addition, conflicting
results have also been found in different Dyrk1A transgenic mice.
Although Souchet et al. [47] found a marked deficit in motor
coordination in mBACtgDyrk1a mice, the TgDyrk1A model
exhibited less impairment in motor learning [9], and another
Dyrk1A model generated using a human BAC [10] does not
exhibit deficits in the rotarod test. These results suggest that
overexpression of Dyrk1A in a segmental trisomic mouse or in
different Dyrk1A transgenic mice does not consistently result in
motor alterations, which is most likely due to differences in the
experimental protocols used. In addition, for the different Dyrk1A
transgenic mice, the different transgenes (human or murine) and/
or promoters may also account for the inconsistent results found in
the rotarod test.
Finally, for Ts65Dn mice, overexpression of genes other than
Dyrk1A in this model may affect the appearance of this phenotype.
This mouse bears a partial trisomy of a segment of Mmu16,
containing approximately 92 genes orthologous to Hsa21 genes
[48]; in addition, the Ts65Dn mouse also carries a trisomy of ,10
Mb of Mmu17 containing 60 genes that are not homologous to
Hsa21 [49]. Thus, the set of genes that are not triplicated in DS
that are trisomic in this model may also modulate or modify
different phenotypes in a manner that differs from that found in
single transgenic mice or other segmental trisomic mice.
Based on the fear conditioning test, the TS +/+/+ mice
exhibited a deficit in both cued and contextual conditioning.
Normalization of the Dyrk1A copy number did not rescue cued
learning but partially ameliorated the alteration in contextual
conditioning found in the TS +/+/+ mice. Cued conditioning
primarily depends on the appropriate function of the amygdala
[50–52], whereas the hippocampus plays a role in learning that
involves context discrimination. However, the cerebellum, which
is a structure that is impaired in the TS mouse (see [1]), and the
entorhinal and perirhinal cortices also appear to be implicated in
contextual learning [53–55]. Therefore, the lack of an effect of the
reduction in the Dyrk1A gene dosage on cued learning and its
Table 1. Motor test battery (mean scores 6 SEM).
MANOVA ‘trisomy6Dyrk1A’
CO +/+ TS +/+/+ TS +/+/2 Karyotype F(1,31) Genotype F(2,31)
Vision 1.6760.15 2.0860.15 1.6660.19 3.62 p = 0.066 3.29 p = 0.079
Righting reflex 2.9160.08 2.9160.08 3.0060.00 0.01 p = 0.94 0.73 p = 0.39
Grip strength 1.7560.13 1.4160.15 1.3460.14 2.28 p = 0.14 0.17 p = 0.68
Latency to fall
off a wooden bar
40.0060.00 39.8360.17 40.0060.00 1.39 p = 0.24 1.45 p = 0.23
Latency to fall
off an aluminum bar
22.9063.36 20.562.96 23.064.15 0.21 p = 0.64 0.24 p = 0.62
Prehensile reflex 2.4160.35 2.4260.28 2.6760.19 0.010 p= 0.92 0.46 p = 0.50
Traction capacity 3.8360.81 2.7560.72 2.9160.88 0.78 p = 0.38 0.02 p = 0.88
Latency to fall
off a coat hanger
32.3366.68 35.3367.16 34.5867.12 0.06 p = 0.80 0.01 p = 0.94
Number of crossings
on a coat hanger
3.3361.31 3.0060.56 3.3460.83 0.097 p= 0.75 0.08 p = 0.77
Latency of arrival
at a coat hanger
12.5064.65 8.5863.18 9.4263.62 0.53 p = 0.47 0.02 p = 0.87
doi:10.1371/journal.pone.0106572.t001
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limited effect in contextual learning may indicate that this gene
does not affect the function of these additional brain areas.
Several studies have implicated Dyrk1A overexpression in the
cognitive phenotype detected in animals carrying extra copies of
this gene [12,13] or in segmental trisomic mice, which also
overexpress the Dyrk1A gene [1,2]. A recent study [7] revealed
that normalization of the Dyrk1A expression level exclusively in
the hippocampus by injecting a viral vector containing inhibitory
Dyrk1A shRNA (AAV2/1-shDyrk1A) did not improve the
learning abilities of TS mice; however, this intervention enhanced
their search strategy during the MWM test. The discrepancy
between these results and the partial rescue of the performance on
the MWM test found in the present study may be explained by the
tissues in which Dyrk1A expression was normalized in each study.
The reference and working memory components and the long-
term consolidation process in the spatial learning component of
the MWM test are dependent on the integrity of not only the
hippocampus but also the prefrontal cortex [56–59], which is a
structure that is also affected in DS [60]. In this study, the Dyrk1A
gene dosage was also normalized in the cortex and, presumably, in
all tissues in which Dyrk1A is overexpressed. Therefore, Dyrk1A
normalization may result in more efficient learning.
Additional support for the role of Dyrk1A in the altered
cognitive abilities found in DS mouse models comes from studies
demonstrating that the pharmacological inhibition of this gene
using epigallocatechin gallate (EGCG), improves hippocampal-
dependent learning and thigmotaxis in TgDyrk1A and Ts65Dn
mice [11,61]. In addition, in a pilot clinical trial of individuals with
DS, administration of EGCG enhanced their accuracy in visual
memory recognition and spatial working memory, suggesting a
positive effect of this compound on the prefrontal system [11].
Interestingly, a recent report implicated Dyrk1A overexpression in
the structural and functional anomalies of the prefrontal cortex
[29]. Therefore, the cognition-enhancing effects of normalization
of the Dyrk1A expression level may be due to its effects on the
hippocampal-prefrontal functional networks that support memory-
related functions.
TS +/+/+ mice are hyperactive under conditions that typically
provoke caution in euploid mice, such as the open field test, and
this hyperactivity is likely due to attentional deficits [21,22]. In the
Figure 4. Normalization of the Dyrk1A copy number rescued LTP in TS mice. (a) Representative fEPSP traces before (gray) and after (black)
TBS stimulation (top row). (b) Time courses of the initial slope of fEPSPs recorded from the CA1 region in hippocampal slices following stimulation of
the Schaffer collateral-commissural pathway. The data are presented as the mean values 6 SEM from 6 slices from 6 different mice in each group
(lower row). ANOVA ‘trisomy’: F(1,17) = 9.34, p = 0.009; ‘Dyrk1A’: F(1,17) = 13.62, p = 0.003.
doi:10.1371/journal.pone.0106572.g004
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present study, normalizing the level of Dyrk1A expression did not
rescue this phenotype in TS mice; this lack of rescue might
contribute to the incomplete improvement in cognitive function
found in TS +/+/2 animals. In contrast to the present results,
Ortiz-Abalia et al. [14] demonstrated that normalization of the
Dyrk1A expression level in the striatum via injection of an adeno-
associated virus type 2-mediated Dyrk1A RNA inhibitor (AAV-
shDyrk1A) rescued motor deficits and attenuated hyperactivity in
TgDyrk1A mice. In the present study, the lack of an effect of
reducing the level of Dyrk1A expression on the hyperactivity of
trisomic animals might indicate that other genes might play a role
in this phenotypic alteration.
Among the putative mechanisms that mediate the cognitive-
enhancing effects of normalizing Dyrk1A expression are the
improvement of synaptic efficacy and the amelioration of the
neuromorphological deficits found in TS mice. Altered synaptic
efficacy is a predominant mechanism underlying cognitive
disturbances in trisomic animals. Hippocampal LTP, which is a
substrate of learning and memory, is altered in TS mice, in other
mouse models of DS and in mouse models that overexpress
Dyrk1A [1,10,29]. In this study, normalization of the Dyrk1A copy
number in the TS mouse completely rescued hippocampal LTP,
indicating that the extra copy of Dyrk1A in this mouse plays a role
in the alteration in synaptic plasticity. Consistent with our results,
pharmacological or genetic inhibition via administration of EGCG
or injection of AAV2/1-shDyrk1A, respectively, enhances hippo-
campal LTP in TS mice [7,62].
Numerous studies have demonstrated that the cognitive
impairment exhibited by the TS mouse model of DS is due to
an imbalance between excitatory and inhibitory neurotransmis-
sion, leading to excessive levels of neuronal inhibition (see [2,23]).
In particular, the marked reduction in LTP in the CA1 and DG
areas of the hippocampus has been associated with enhanced
GABA-mediated inhibition [62–65], as the impairments in
synaptic plasticity and cognitive disturbances could be rescued in
the TS mouse by administering various antagonists or negative
allosteric modulators of the GABAA receptor [20,63,64,66,67].
Consistent with the increased levels of GABAergic synaptic
proteins in the cortex and hippocampus of TS mice [20,65,68],
in this study, we found enhanced expression of GAD65/67, which
is a marker of GABAergic synapses, and reduced expression of
VGLUT, which is a marker of glutamatergic synapses. Removing
one copy of the Dyrk1A gene reduced GAD65/67 and enhanced
VGLUT expression, respectively, to levels similar to those of
euploid animals. Additional support for the role of Dyrk1A in the
enhanced inhibition comes from a recent study [47] that assessed
the contribution of Dyrk1A gene dosage to this enhanced
inhibition. This study demonstrated that increased dosage of
Figure 5. Normalization of the Dyrk1A copy number reduced the density of GABAergic and increased the density of glutamatergic
synapse markers in the hippocampus of TS mice. (a) Representative images of GAD65/67, VGLUT and GAD6567/VGLUT immunostaining. (b)
Mean values6 SEM of the percentage of area occupied by GAD65/67- (top row) and VGLUT-positive boutons (middle row) in the hippocampus of TS
+/+/+, TS +/+/2 and CO +/+ mice and the ratio of these areas (lower row). GAD65/67: ANOVA ‘trisomy’: F(1,17) = 10.10, p = 0.006; ‘Dyrk1A’:
F(1,17) = 3.91, p = 0.066. VGLUT: ANOVA ‘trisomy’: F(1,17) = 10.35, p = 0.006; ‘Dyrk1A’: F(1,17) = 4.49, p = 0.051; Ratio GAD/VGLUT: ANOVA ‘trisomy’:
F(1,17) = 37.44, p,0.001; ‘Dyrk1A’: F(1,23) = 9.30, p = 0.009. **: p,0.01, ***: p,0.001 TS +/+/+ vs. CO +/+; #: p,0.05 TS +/+/+ vs. TS +/+/2.
doi:10.1371/journal.pone.0106572.g005
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Dyrk1A in mBACtgDyrk1a, Ts65Dn and Dp(16)1Yey mice
carrying 3 copies of this gene led to an increased number and
signal intensity of two markers of GABAergic synapses, GAD67
and VGAT. These authors propose that the increase in GAD67
staining in mBACtgDyrk1a mice could be indicative of an increase
in the proportion of neurons that acquire a GABAergic phenotype
during neuronal differentiation. In contrast, Dyrk1A (+/2) mice,
which carry one functional copy of this gene, exhibited reduced
expression of this inhibitory synapse marker. In addition, as
observed in the present study, these authors also found increased
expression of the VGLUT1 marker of excitatory synapses in the
mouse models bearing three copies of Dyrk1A in comparison to
euploid mice. These results provide additional support for the role
of Dyrk1A overexpression in the overinhibition found in Ts65Dn
mice.
However, in our study, the ratio of excitatory to inhibitory
synapse markers was not completely restored, suggesting that
additional orthologous Hsa21 genes may be involved in this
imbalance. Indeed, it has been shown that triplication of the Olig1
and Olig2 genes, which are also in Hsa21, is also implicated in the
increased number of inhibitory neurons found in the forebrains of
TS mice, which is accompanied by an increase in spontaneous
inhibitory postsynaptic currents in pyramidal neurons in the CA1
area [69].
TS +/+/+ mice exhibit alterations in pre- and post-natal
neurogenesis (see [1]). Adult hippocampal neurogenesis plays a
role in the establishment of LTP and hippocampal-dependent
learning and memory [26–28]. Consistent with this notion, it has
recently been demonstrated that restoration of neurogenesis via
administration of fluoxetine, lithium or RO4938581, which is a
Figure 6. Normalization of the Dyrk1A gene dosage increased cell proliferation and differentiation in the DG but did not rescue the
density of mature granule neurons. (a) Representative images of Ki67, DCX, CLR and DAPI labeling in the DG. (b) Mean values 6 SEM of the
density of Ki67-, DCX-, CLR- and DAPI-positive cells of TS mice trisomic (+/+/+) and disomic (+/+/2) for Dyrk1A and euploid (CO +/+) mice. Ki67:
ANOVA ‘trisomy’: F(1,17) = 5.60, p = 0.032; ‘Dyrk1A’: F(1,17) = 7.31, p = 0.017. DCX: ANOVA ‘trisomy’: F(1,17) = 7.37, p = 0.016; ‘Dyrk1A’: F(1,17) = 3.79,;
p = 0.071. CLR: ANOVA ‘trisomy’: F(1,17) = 0.94 p= 0.34; ‘Dyrk1A’: F(1,17) = 5.56, p = 0.032. DAPI: ANOVA ‘trisomy’: F(1173) = 13.43, p = 0.003; ‘Dyrk1A’:
F(1,17) = 1.77, p = 0.20. *: p,0.05 TS +/+/+ vs. CO +/+; #: p,0.05 TS +/+/2 vs. TS +/+/+; Bonferroni tests after significant MANOVAs.
doi:10.1371/journal.pone.0106572.g006
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negative allosteric modulator of the a5 subunit of the GABAA
receptor [3,20,70], to TS mice enhances their cognitive abilities.
In this study, normalization of the Dyrk1A dosage rescued the
density of proliferating (Ki67+) cells and increased the number of
immature neurons (DCX+ and CLR+ cells) in TS mice.
Consistent with these results, pharmacological (EGCG adminis-
tration) or genetic (shRNA injection) strategies targeting Dyrk1A
have been shown to abolish the proliferation and differentiation
defects in iPSCs derived from an individual with DS [71]. Dyrk1A
has been shown to interact and modulate various signaling
pathways (including EGF, FGF, NGF, SHH, NFAT and Notch,
among others) that play a role during different stages of cell
proliferation and differentiation [6]. Therefore, normalization of
the Dyrk1A gene dosage may aid in restoring the normal function
of different molecular targets, resulting in increased adult neuronal
proliferation. Because both proliferating and immature differen-
tiating cells in the hippocampus play a role in cognitive processing
during adulthood [72,73], normalization of the Dyrk1A expression
level may improve the cognitive performance of TS +/+/2
animals by increasing the density of proliferating or differentiating
cells. However, the Olig1 and Olig2 genes have also been found to
modulate some of these pathways (including FGF, Notch and
SHH) [74,75]; therefore, an interplay between the effects of these
genes on the different molecular targets may lead to several altered
phenotypes of the Ts65Dn mouse.
In this study, the TS +/+/+ mice also displayed a reduced
density of hippocampal mature granule (DAPI+) neurons.
Although studies have demonstrated that DYRK1A promotes cell
survival in cultures [76], in this study, normalization of the
Dyrk1A expression level did not increase the density of mature
surviving granule neurons in the hippocampus of TS mice. One
mechanism that has been shown to enhance survival in vitro and
in vivo in some tissues is the anti-apoptotic effect of DYRK1A
[76–78]. However, the reduced cellularity found in different areas
of the adult TS brain is most likely not due to changes in apoptosis
[37,79]. Thus, the anti-apoptotic effect of Dyrk1A might not affect
the survival of mature neurons in the hippocampus when the gene
dosage is normalized in TS mice. In addition, trisomy of other
genes in TS mice might also be involved in the lack of a pro-
survival effect after normalizing the Dyrk1A expression level.
Several studies have associated Dyrk1A gene dosage with brain
volume [5,10,13]; however, consistent with the lack of an effect of
normalization of the Dyrk1A copy number on the density of
mature granule neurons, in this study, normalization of the
Dyrk1A gene dosage did not affect the DG volume, the SGZ area
or the body weight of TS animals, suggesting that other genes may
be involved in these developmental alterations. Thus, the present
results support the notion that Dyrk1A gene dosage plays a role in
some of the functional, but not the structural, alterations detected
in the TS mouse.
Figure 7. Reduction of the Dyrk1A gene copy number did not rescue the reduced DG volume, SGZ area or body weight in TS mice.
Mean values6 SEM of the DG volume (a), SGZ area (b) and body weight (c) of TS +/+/+ and TS +/+/2 mice and of euploid mice. DG volume: ANOVA
‘trisomy’: F(1,17) = 4.94, p = 0.043; ‘Dyrk1A’: F(1,17) = 0.13, p = 0.72. SGZ area: ANOVA ‘trisomy’: F(1,17) = 12.14, p = 0.003; ‘Dyrk1A’: F(1,17) = 0.01,
p = 0.89. Body weight: ANOVA ‘trisomy’: F(1,31) = 62.98, p,0.001; ‘Dyrk1A’: F(1,31) = 1.31, p = 0.026. *: p,0.05, **: p,0.01, ***: p,0.001 TS vs. CO;
Bonferroni tests after significant MANOVAs.
doi:10.1371/journal.pone.0106572.g007
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In conclusion, we demonstrate that normalization of the
Dyrk1A copy number enhanced hippocampal-dependent learning
deficits presumably by normalizing synaptic plasticity (LTP),
improving the balance between excitatory and inhibitory synapse
markers and/or reducing the alterations in hippocampal mor-
phology (neural proliferation and differentiation) in TS mice.
These results indicate that Dyrk1A overexpression plays an
important role in several key DS phenotypes and suggest that
pharmacological strategies targeting this gene or the Dyrk1A
kinase could alleviate DS-associated learning disabilities.
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